Skip to main content

DnB Asset Management AS

SEC CIK
0001456670
Latest filing
Aug 11, 2026

ABT holding history

Abbott Laboratories in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
841,310
Value
$76.3M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by DnB Asset Management AS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026841,310$76.3M0.2%+257,360+44.1%AddedHolders
Q1 2026583,950$60.0M0.2%+104,244+21.7%AddedHolders
Q4 2025479,706$60.1M0.2%+15,578+3.4%AddedHolders
Q3 2025464,128$62.2M0.2%−34,333−6.9%ReducedHolders
Q2 2025498,461$67.8M0.3%−56,935−10.3%ReducedHolders
Q1 2025555,396$73.7M0.3%−18,174−3.2%ReducedHolders
Q4 2024573,570$64.9M0.3%+19,226+3.5%AddedHolders
Q3 2024554,344$63.2M0.3%+27,435+5.2%AddedHolders
Q2 2024526,909$54.8M0.3%+76,420+17.0%AddedHolders
Q1 2024450,489$51.2M0.3%−5,275−1.2%ReducedHolders
Q4 2023455,764$50.2M0.3%−14,678−3.1%ReducedHolders
Q3 2023470,442$45.6M0.3%+16,188+3.6%AddedHolders
Q2 2023454,254$49.5M0.3%+9,739+2.2%AddedHolders
Q1 2023444,515$45.0M0.3%+5,116+1.2%AddedHolders
Q4 2022439,399$48.2M0.3%+15,113+3.6%AddedHolders
Q3 2022424,286$41.1M0.3%−4,522−1.1%ReducedHolders
Q2 2022428,808$46.6M0.3%−1,646−0.4%ReducedHolders
Q1 2022430,454$50.9M0.3%+19,755+4.8%AddedHolders
Q4 2021410,699$57.8M0.3%+774+0.2%AddedHolders
Q3 2021409,925$48.4M0.3%+40,189+10.9%AddedHolders
Q2 2021369,736$42.9M0.3%+36,824+11.1%AddedHolders
Q1 2021332,912$39.9M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.